IncFact
Company Profiles: Revenue, Growth, Competition

PRELUDE THERAPEUTICS Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Prelude Therapeutics

Access the complete profile.

Prelude Therapeutics Fast Facts

Revenue$10 - $100 million    See Exact Annual Revenue
Employees100 - 500Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Address200 Powder Mill Rd
Wilmington, DE 19803

preludetx.com
Note: Revenues for privately held companies are statistical evaluations.


Prelude Therapeutics's annual revenues are $10-$50 million (see exact revenue data) and has 100-500 employees. It is classified as operating in the Scientific Research & Development Services industry.


Prelude Therapeutics's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Prelude Therapeutics Annual Revenue and Growth Rate

Prelude Therapeutics Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Prelude Therapeutics's revenues are gauged from an analysis of company filings.



Prelude Therapeutics's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Prelude Therapeutics Revenue (Sales) Prelude Therapeutics Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Prelude Therapeutics is developing and marketing. Prelude Therapeutics doesn't have any recent trademark applications, indicating Prelude Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
PRELUDE THERAPEUTICS
Research and development of drugs in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research for medical purposes in the fields of oncology, hematology, autoimmune diseases, and rare diseases; clinical research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; scientific research and development of pharmaceuticals and biopharmaceuticals for the treatment of cancer, hematological diseases, autoimmune diseases, and rare diseases; providing websites featuring medical and scientific research information about pharmaceutical and biopharmaceutical drugs and their preparations; genetic testing for scientific research; genetic research in the fields of oncology, hematology, autoimmune diseases, and rare diseases; none of the foregoing in relation to or in the field of fertility services
05/31/2019

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Prelude Therapeutics grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Prelude Therapeutics is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Prelude Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Prelude Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSReston, VA100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM31 
INC RESEARCHRaleigh, NC28 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
ILLUMINASan Diego, CA13 
UT-BATTELLEOak Ridge, TN12 
PRA HOLDINGSRaleigh, NC12 
BATTELLE ENERGY ALLIANCEIdaho Falls, ID11 




Nearby Competitors

These companies are similar in business line and location to Prelude Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
INCYTEWilmington, DE100 
INTERDIGITAL COMMUNICATIONSWilmington, DE12 
PRELUDE THERAPEUTICSWilmington, DE8 
BIOSPECIFICS TECHNOLOGIESWilmington, DE6 
NIKANG THERAPEUTICSWilmington, DE3 
CLOVER BIOPHARMACEUTICALS USA INWilmington, DE2 




Future Competition: Prelude Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Prelude Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Prelude Therapeutics Competitors